The impact of using a low-literacy patient education tool on process measures of diabetes care in a minority population

Journal of the National Medical Association

Volumn 95, Issue 11, 2003, Pages 1074-1081

  Echeverry, Diana M ^a   Dike, Margie R ^a   Washington, Courtney ^a   Davidson, Mayer B ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Diabetes care; Diabetes guidelines; Low literacy; Process measures; Quality

Indexed keywords

ADULT; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; EDUCATION PROGRAM; EDUCATIONAL TECHNOLOGY; ETHNIC GROUP; FEMALE; FOOT; HEALTH CARE UTILIZATION; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MINORITY GROUP; NEGRO; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; READING; REVIEW; SINGLE BLIND PROCEDURE; UNITED STATES; URINALYSIS;

AFRICAN AMERICANS; COMMUNITY HEALTH CENTERS; DELIVERY OF HEALTH CARE; DIABETES MELLITUS; EDUCATIONAL STATUS; FEMALE; GUIDELINE ADHERENCE; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; MINORITY GROUPS; PATIENT EDUCATION; PRACTICE GUIDELINES; REMINDER SYSTEMS; SINGLE-BLIND METHOD;

EID: 0242440740     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. American Diabetes Association: Diabetic Nephropathy. Diabetes Care. 2002;25:S85-S89.
2. Maser RE, Steenkiste AR, Dorman JS, et al. Epidemiologic correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes. 1989; 38:1456-1461.
3. Ailello LP, Gardner TW, King GL, et al. Diabetic Retinopathy (Technical review) Diabetes Care. 1998;21:143-156.
4. Yu CM, Lau CP, Cheung B, et al. Clinical Predictors of Morbidity and Mortality in Patients with Myocardial Infarction or Revascularization who underwent Cardiac Rehabilitation, and Importance of Diabetes Mellitus and Exercise Capacity. The American Journal of Cardiology. 2000;85:344-349.
5. Roesen P, Ferber P, Tschoepe D. Macrovascular Disease in diabetes: Current Status. Experimental and Clinical Endocrinology. 2001;109:Suppl 2:S474-486.
6. Calles-Escandon J, Cipolla M. Diabetes and Endothelial Dysfunction: A clinical perspective. Endocrine Reviews. 2001;22: 36-52.
7. Davidson MB. Evidence-Based Performance and Outcome Measures for Diabetes Care, Disease Management Health Outcomes. 1997;2:124-133.
8. Davidson M. Diabetes Care in Health-Maintenance-Organization and Fee-for-Service Settings. Disease Management Health Outcomes. 1997;2:189-197.
9. United States General Accounting Office. Report to the Chairman, Subcommittee on Health and Environment, Committee on Commerce, House of Representatives; Most Beneficiaries with Diabetes Do Not Receive Recommended Monitoring Services. MEDICARE. 1997.
10. Saaddine J, Engelgau M, Beckles G, et al. A Diabetes Report Card for the United States: Quality of Care in the 1990s. Annals of Internal Medicine. 2002;136:565-574.
11. Wilson PW, Anderson KM, Castelli WP. Twelve-year incidence of coronary heart disease in middle-aged adults during the era of hypertensive therapy: the Framingham Offspring Study. Am J Med. 1991;90:11-16. [Erratum, Am J Med. 1991;90:537].
12. Wilson PW, Anderson KM, Castelli WP. Twelve-year incidence of coronary heart disease in middle-aged adults during the era of hypertensive therapy: the Framingham Offspring Study. Am J Med. 1991;90:11-16. [Erratum, Am J Med. 1991;90:537].
13. Kalmel WB, McGee DL. Diabetes and Cardiovascular Risk Factors: The Framingham Study. Circulation. 1979;59:8-13.
14. Roesen P, Ferber P, Tschoepe D: Macrovascular Disease in Diabetes: Current Status. Experimental and Clinical Endocrinology and Diabetes. 2001;109:Suppl 2:S474-86.
15. Anonymous: Effect of intensive therapy on the development and progression of diabetic nephropathy in the diabetes control and complications trial. The Diabetes Control and Complications (DCCT) Research Group. Kidney International. 1995;47:1703-1720.
16. The Diabetes Control and Complications Trial Research Group. The effect of intensive therapy on the development and progression of neuropathy. Annals of Internal Medicine. 1995; 122:561-568.
17. The Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure to (HbA sub 1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes. 1995; 44:968-983.
18. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with noninsulin-dependent diabetes mellitus: A randomized prospective six-year study. Diabetes Research and Clinical Practice. 1995;28:103-117.
19. Jacobson TA, Thomas DM, Morton FJ, et al. Use of a Low-Literacy Patient Education Tool to Enhance Pneumococcal Vaccination Rates: A Randomized Controlled Trial. JAMA. 1999;282:646-650.
20. Davis TC, Berkel HL, Arnold CL, et al. Intervention to increase mammography utilization in a public hospital. J Gen Intern Med. 1998;13:230-233.
21. Carter JS, Pugh JA, Monterrosa. A Noninsulin dependent diabetes in minorities in the United States. Ann Int Med. 1996; 125:221-232.
22. Harris MI, Klein R, Cowie CC, et al. Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type-2 diabetes? A U.S. population study. Diabetes Care. 1998;21:1230-1235.
23. Arfken CL, Reno PL, Santiago JV, et al. Development of proliferative diabetic retinopathy in African Americans and whites with type-1 diabetes. Diabetes Care. 1998;21:792-795.
24. Cowie CC, Port FK, Wolfe RA, et al. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes: N Engl J Med. 1989;321:1074-1079.
25. Brooks RJ, Legorreta AP. Implementing guidelines for eye care of diabetic patients: results from an HMO intervention study. Am J Managed Care. 1996;365-369.
26. Legoretta A, Hasan M, Peters A, et al. An Intervention for Enhancing Compliance with Screening Recommendations for Diabetic Retinopathy: A Bicoastal Experience. Diabetes Care. 1997;20:520-523.
27. Lobach DF, Hammond WE. Computerized decision support based on a clinical practice guideline improves compliance with care standards. Am J Med. 1997;102:89-98.
28. Deichmann RE, Castello E, Horswell R, et al. Improvements in diabetes care as measured by HbA1c after a physician education project. Diabetes Care. 1999;22:1612-1616.